1. Home
  2. MANU vs CELC Comparison

MANU vs CELC Comparison

Compare MANU & CELC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Manchester United Ltd.

MANU

Manchester United Ltd.

HOLD

Current Price

$17.48

Market Cap

2.8B

ML Signal

HOLD

Logo Celcuity Inc.

CELC

Celcuity Inc.

HOLD

Current Price

$115.40

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MANU
CELC
Founded
1878
2011
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.1B
IPO Year
2012
2017

Fundamental Metrics

Financial Performance
Metric
MANU
CELC
Price
$17.48
$115.40
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$107.88
AVG Volume (30 Days)
300.5K
646.7K
Earning Date
02-25-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.08
N/A
Revenue Next Year
$15.75
$706.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.13
$7.61
52 Week High
$18.94
$120.32

Technical Indicators

Market Signals
Indicator
MANU
CELC
Relative Strength Index (RSI) 59.06 55.64
Support Level $17.09 $99.38
Resistance Level $18.13 $117.61
Average True Range (ATR) 0.36 6.16
MACD 0.15 0.41
Stochastic Oscillator 80.12 80.51

Price Performance

Historical Comparison
MANU
CELC

About MANU Manchester United Ltd.

Manchester United PLC operates as a professional football club with related activities, generating revenue prominently through commercial, broadcasting, and matchday segments. The commercial segment monetizes the various brands via sponsorships, retail, merchandising, apparel, and product licensing. Broadcasting revenue comes from television rights linked to football leagues and competitions, alongside content delivered through its dedicated TV channel all over the globe. Matchday income includes ticket sales, hospitality, merchandise, and services at its stadium. Manchester United is based in England. The company's operations and fan base extends to many countries, supporting a diversified revenue model based on brand engagement and football-related content.

About CELC Celcuity Inc.

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.

Share on Social Networks: